These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2902445)

  • 1. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
    Brook MG
    Lancet; 1988 Oct; 2(8618):1017-8. PubMed ID: 2902445
    [No Abstract]   [Full Text] [Related]  

  • 2. A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen.
    Doshi JC; Vaidya AB; Antarkar DS; Deolalikar R; Antani DH
    Indian J Gastroenterol; 1994 Jan; 13(1):7-8. PubMed ID: 8119752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers.
    Thamlikitkul V; Wasuwat S; Kanchanapee P
    J Med Assoc Thai; 1991 Sep; 74(9):381-5. PubMed ID: 1791391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus.
    Milne A; Hopkirk N; Lucas CR; Waldon J; Foo Y
    N Z Med J; 1994 Jun; 107(980):243. PubMed ID: 8208497
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of chronic type B viral hepatitis.
    Aach RD
    Ann Intern Med; 1988 Jul; 109(2):89-91. PubMed ID: 3289432
    [No Abstract]   [Full Text] [Related]  

  • 6. Phyllanthus amarus and hepatitis B.
    Thyagarajan SP; Jayaram S; Valliammai T; Madanagopalan N; Pal VG; Jayaraman K
    Lancet; 1990 Oct; 336(8720):949-50. PubMed ID: 1976968
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon in chronic hepatitis B.
    Gregory PB
    Gastroenterology; 1986 Jan; 90(1):237-40. PubMed ID: 3940248
    [No Abstract]   [Full Text] [Related]  

  • 8. Phyllanthus trial.
    Sloan DS
    N Z Med J; 1994 Nov; 107(990):494. PubMed ID: 7695705
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
    Thyagarajan SP; Subramanian S; Thirunalasundari T; Venkateswaran PS; Blumberg BS
    Lancet; 1988 Oct; 2(8614):764-6. PubMed ID: 2901611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
    Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
    J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe exacerbation of chronic hepatitis B following interferon therapy].
    Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
    Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.
    McDonald EM; Mann AH; Thomas HC
    Lancet; 1987 Nov; 2(8569):1175-8. PubMed ID: 2890808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subclasses of antibodies to hepatitis B core antigen in chronic HBV infections: changes during treatment with interferons and predictors of response].
    Cheng GM; Karayiannis P; Thomas HC
    Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):141-3, 188-9. PubMed ID: 1698593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic viral hepatitis--new data on its pathogenesis and treatment].
    Naumov N
    Vutr Boles; 1991; 30(2):13-20. PubMed ID: 1654013
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.
    Rodríguez-Iñigo E; Bartolomé J; López-Alcorocho JM; Contonat T; Oliva H; Carreño V
    J Med Virol; 1997 Sep; 53(1):76-80. PubMed ID: 9298736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of hepatitis B virus DNA in chronic HbsAg carriers: relation to other markers of viral replication].
    Bartolomé Nebreda FJ; Castillo Aguilar I; Mora Pérez I; Gutiez Cuevas J; Hernández-Guio C; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1986 May; 178(9):432-5. PubMed ID: 3738030
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of human recombinant interleukin 2 in patients with chronic hepatitis B: a preliminary report.
    Nishioka M; Kagawa H; Shirai M; Terada S; Watanabe S
    Am J Gastroenterol; 1987 May; 82(5):438-42. PubMed ID: 3495171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers.
    Leelarasamee A; Trakulsomboon S; Maunwongyathi P; Somanabandhu A; Pidetcha P; Matrakool B; Lebnak T; Ridthimat W; Chandanayingyong D
    Lancet; 1990 Jun; 335(8705):1600-1. PubMed ID: 1972525
    [No Abstract]   [Full Text] [Related]  

  • 20. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
    Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.